Analyst Consensus ?
ConsensusHold39 ratings
Bullish1948.7%
Neutral1948.7%
Bearish12.6%
FN2 Earnings Intelligence
Xylem Inc. complete analyst coverage
Xylem Inc. (XYL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$117.78Current
$107Low
$149.28Average
$170High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Stifel | Buy | Buy | Maintain | Jul 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 25, 2026 |
| UBS | Neutral | Neutral | Maintain | Apr 29, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 16, 2026 |
| TD Cowen | Hold | Hold | Maintain | Dec 5, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Argus Research | Buy | Buy | Maintain | May 29, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Nov 21, 2023 |
| Melius Research | Buy | Hold | Upgrade | Oct 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 14, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Raymond James | Underperform | Market Perform | Downgrade | Jan 4, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 16, 2022 |
| Goldman Sachs | Neutral | Neutral | Maintain | Nov 3, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Nov 2, 2022 |
| Rosenblatt | Hold | Buy | Downgrade | Oct 1, 2021 |
| Janney Montgomery Scott | Neutral | Neutral | Maintain | Jun 3, 2020 |
| Janney Capital | Neutral | Neutral | Maintain | Jun 3, 2020 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 7, 2020 |
| Seaport Global | Neutral | Buy | Downgrade | Nov 4, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 31, 2018 |
| Vertical Research | Hold | Sell | Upgrade | Oct 18, 2018 |
| Boenning & Scattergood | Neutral | Outperform | Downgrade | Nov 28, 2016 |
| Wedbush | Neutral | Outperform | Downgrade | Apr 11, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 5, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 5, 2016 |
| DA Davidson | Neutral | Neutral | Maintain | Oct 29, 2014 |
| Keybanc | Hold | Buy | Downgrade | Oct 30, 2013 |
| Brean Capital | Buy | Hold | Upgrade | Oct 29, 2013 |
| BB&T Capital | Hold | Buy | Downgrade | Jul 30, 2013 |
| CL King | Neutral | Buy | Downgrade | Apr 15, 2013 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 18, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $117.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $130 | $124.97 | +10.4% | Jul 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $160 | $124.97 | +35.9% | Jul 29, 2026 |
| Robert W. Baird | Michael Halloran | $165 | $124.97 | +40.1% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $159 | $124.97 | +35.0% | Jul 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $157 | $122.78 | +33.3% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $159 | $124.53 | +35.0% | Jul 16, 2026 |
| Jefferies | Stephen Volkmann | $140 | $112.04 | +18.9% | Jun 25, 2026 |
| UBS | Analyst unavailable | $133 | $116.4 | +12.9% | Apr 29, 2026 |
| Oppenheimer | Bryan Blair | $158 | $116.4 | +34.2% | Apr 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $159 | $117.91 | +35.0% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $154 | $117.91 | +30.8% | Apr 29, 2026 |
| UBS | Analyst unavailable | $132 | $120.46 | +12.1% | Apr 21, 2026 |
| Stifel Nicolaus | Nathan Jones | $163 | $128.85 | +38.4% | Apr 14, 2026 |
| UBS | Joshua Spector | $152 | $129.4 | +29.1% | Apr 9, 2026 |
| UBS | Joshua Spector | $155 | $128.2 | +31.6% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $165 | $127.02 | +40.1% | Feb 12, 2026 |
| Goldman Sachs | Analyst unavailable | $158 | $126.77 | +34.2% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $138 | $128.18 | +17.2% | Feb 11, 2026 |
| Stifel Nicolaus | Analyst unavailable | $175 | $128.92 | +48.6% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $161 | $128.92 | +36.7% | Feb 11, 2026 |
| Barclays | William Grippin | $166 | $141.33 | +40.9% | Jan 7, 2026 |
| Mizuho Securities | Brett Linzey | $150 | $137.11 | +27.4% | Jan 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $178 | $153.42 | +51.1% | Oct 29, 2025 |
| Argus Research | Analyst unavailable | $170 | $153.4 | +44.3% | Oct 29, 2025 |
| Mizuho Securities | Brett Linzey | $160 | $150.5 | +35.9% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $176 | $153.48 | +49.4% | Oct 29, 2025 |
| Robert W. Baird | Michael Halloran | $178 | $153.48 | +51.1% | Oct 29, 2025 |
| Barclays | William Grippin | $172 | $150.5 | +46.0% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $165 | $142.18 | +40.1% | Sep 18, 2025 |
| UBS | Analyst unavailable | $168 | $143.61 | +42.6% | Aug 5, 2025 |
| UBS | Damian Karas | $165 | $127.5 | +40.1% | Aug 13, 2024 |
| Robert W. Baird | Michael Halloran | $170 | $133.48 | +44.3% | Jul 31, 2024 |
| Oppenheimer | Bryan Blair | $152 | $139.4 | +29.1% | May 31, 2024 |
| Argus Research | John Eade | $165 | $140.36 | +40.1% | May 29, 2024 |
| Mizuho Securities | Brett Linzey | $135 | $135.99 | +14.6% | May 3, 2024 |
| RBC Capital | Deane Dray | $162 | $135.99 | +37.6% | May 3, 2024 |
| Robert W. Baird | Michael Halloran | $155 | $135.99 | +31.6% | May 3, 2024 |
| Wolfe Research | Brad Hewitt | $143 | $128.27 | +21.4% | Apr 8, 2024 |
| RBC Capital | Deane Dray | $153 | $127.25 | +29.9% | Apr 4, 2024 |
| Stifel Nicolaus | Nathan Jones | $133 | $99.8 | +12.9% | Aug 18, 2023 |
| Citigroup | Analyst unavailable | $121 | $106.85 | +2.7% | Feb 8, 2023 |
| Citigroup | Analyst unavailable | $123 | $111.23 | +4.4% | Dec 9, 2022 |
| Atlantic Equities | Richard Radbourne | $129 | $112.13 | +9.5% | Nov 16, 2022 |
| Loop Capital Markets | Scott Graham | $120 | $127.19 | +1.9% | Nov 22, 2021 |
| Argus Research | John Eade | $150 | $129.82 | +27.4% | Nov 12, 2021 |
| Citigroup | Andrew Kaplowitz | $131 | $125.7 | +11.2% | Aug 4, 2021 |
| Goldman Sachs | Brian K. Lee | $107 | $116.2 | -9.1% | May 5, 2021 |
Track every rating change on XYL the moment it posts. Free to start.
Start free